Botensilimab,balstilimab
agenus
[]
$agen presentation today at #gi23! previous ph1 botensilimab data in crc presented at #sitc22 in nov 2022 bot/bal combo showed 22% orr excited to see how bot/bal still compares to soc &amp; how responses have continued over time $xbi $ibb #biotech 
Catalyst Calendar, Big Mover™ stocks to watch, & model portfolios. Database & tools to help with your biotech stock research & analysis. not investment advice.